AG10, an orally available, novel transthyretin (TTR) stabilizer: integrated preclinical evaluation predicts a highly effective treatment for TTR amyloid cardiomyopathy
29 August 2017 (15:35 - 16:25)
Organised by:
Abstract
About the speaker
University of the Pacific, Stockton (United States of America)
6 More presentations in this session
Mr M. Nicol (Paris, FR)
Doctor V. Rameev (Moscow, RU)
Professor T. Damy (Creteil, FR)
Doctor G. Lima Da Silva (Lisbon, PT)
Access the full session
The Event
ESC Congress 2017
29 August 2017
15:35 CET
